Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.
Take action
Contact the company
📍Recalling firmUS Compounding Inc1270 Dons Ln · Conway, AR 72032-4753
✎ GovInfoNow plain-language explainer
US Compounding Inc is recalling 1,931 single-use syringes of LET Gel 4% due to labeling errors. The labels are printed with placeholder text for the lot number and expiration date instead of actual values. This makes it impossible to verify the product's identity or shelf life. Read more at govinfonow.com/recall/39230-us-compounding-recalls-let-gel-4-due-to-labeling-errors.
“US Compounding Recalls LET Gel 4% Due to Labeling Errors.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/39230-us-compounding-recalls-let-gel-4-due-to-labeling-errors. Based on FDA recall #D-0482-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0482-2019%22&limit=1).
The FDA announced on Jan. 24, 2019, that US Compounding Inc voluntarily recalled LET Gel 4% syringes due to labeling errors where lot and expiration dates were missing or printed incorrectly. Owners should contact the company at 800-718-3588 for information.
How to tell if you have it
Brand: US Compounding
Product: LET Gel 4% Syringe
Description: Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%, 3mL Single Use Syringe, Rx only
UPC: 62295501303
UPC: 6229550130
The hazard
According to the FDA, the hazard involves labeling errors where labels are missing lot and expiration dates or are printed as Lot# YYYDDYY@XX with a Beyond Use Date of MM/DD/YYY.
Context
GovInfoNow's records show US Compounding Inc has 6 other recalls on record since May 16, 2014. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall (April 16, 2026), Sandoz Focalin XR 5mg Capsules (June 1, 2026), and ICU Medical Recalls Potassium Chloride Injection (Oct. 29, 2025).
How to tell if you have this one
Look for a 3mL single-use syringe labeled as LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%). Check the label for the specific placeholder text 'Lot# YYYDDYY@XX' and 'Beyond Use Date: MM/DD/YYY'. The barcode is 62295501303.
Brand
US Compounding
Product
LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syringe, Rx only, US
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Syringe
Inspect the label on your syringe for the placeholder lot and expiration date text instead of real numbers.
Contact Your Provider
If you have this product, contact your healthcare provider or pharmacist to determine if it should be returned or replaced.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0482-2019 (January 24, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0482-2019 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.